FREDUN PHARMACEUTICALS   
                    
                    
                                                     
                                
                                                                 Back to All Ratios 
                                                
                     | 
                        
                        
                        
                        
                    
FREDUN PHARMACEUTICALS Last 5 Year Profit After Tax (PAT) Margin History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| PAT Margin (%) | 4.49 | 3.93 | 2.82 | 1.50 | 1.69 | 
What is the latest Profit After Tax (PAT) Margin ratio of FREDUN PHARMACEUTICALS ?
| Year | Profit After Tax (PAT) Margin | 
|---|---|
| Mar2024 | 4.49 | 
| Mar2023 | 3.93 | 
| Mar2022 | 2.82 | 
| Mar2021 | 1.50 | 
| Mar2020 | 1.69 | 
How is Profit After Tax (PAT) Margin of FREDUN PHARMACEUTICALS Trending?
| Years | Profit After Tax (PAT) Margin | % Change | |
|---|---|---|---|
| Mar2024 | 4.49 | 14.25 | |
| Mar2023 | 3.93 | 39.36 | |
| Mar2022 | 2.82 | 88.00 | |
| Mar2021 | 1.5 | -11.24 | |
| Mar2020 | 1.69 | - | |
Other Financial Ratios of FREDUN PHARMACEUTICALS
| Operational &  Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate  | Margin  Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin Cash Profit Margin  | Performance  Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales  | Efficiency  Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days  | Valuation  Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales  | Growth  Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth  | Financial Stability  Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap  | 
Compare Profit After Tax (PAT) Margin ratio of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹730.4 Cr | -9% | 16.9% | 118.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹409,626.0 Cr | 1.2% | 4.4% | -9.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,669.0 Cr | 5.8% | 19.2% | 16.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹122,793.0 Cr | 1.4% | 1.8% | 10.8% | Stock Analytics | |
| CIPLA | ₹122,103.0 Cr | -3.7% | -0.2% | 1.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,857.4 Cr | -7.3% | -4% | -6.1% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| FREDUN PHARMACEUTICALS |    -9%  | 
                            
                     
                     16.9%  | 
                     
                     118.2%  | 
                    
| SENSEX |    -0.9%  |    
                      
                    
                     4.6%  | 
                     
                     5%  | 
                    
You may also like the below Video Courses